Table 2.
Exposure to antineoplastic drugs at work, Porto Alegre, Brazil, 2014
| Exposure | ||||
| Yes | 9 (33.3) | 11 (40.7) | 7 (25.9) | 27 (67.5) |
| No | 2 (15.4) | 3 (23.1) | 8 (61.5) | 13 (32.5) |
| Number of exposure events | ||||
| Less than 5 | 5 (33.3) | 7 (46.7) | 3 (20.0) | 15 (55.6) |
| 5 to 15 | 3 (30.0) | 3 (30.0) | 4 (40.0) | 10 (37.0) |
| More than 15 | 1 (50.0) | 1 (50.0) | 0 (0.0) | 2 (7.4) |
| Type of exposure | ||||
| Aerosols | 1 (25.0) | 2 (50.0) | 1 (25.0) | 4 (14.8) |
| Contact | 9 (34.6) | 11 (42.3) | 6 (23.1) | 26 (96.3) |
| Ingestion | 0 (0.0) | 0 (0.0) | 1 (100.0) | 1 (3.7) |
| Inhalation of medication | 0 (0.0) | 1 (100) | 0 (0.0) | 1 (3.7) |
| Symptom | ||||
| Yes | 3 (37.5) | 3 (37.5) | 2 (25.0) | 8 (29.6) |
| No | 6 (31.6) | 8 (42.1) | 5 (26.3) | 19 (70.4) |
| Work accident statement | ||||
| Yes | 2 (16.7) | 6 (50.0) | 4 (33.3) | 12 (44.4) |
| No | 7 (50.0) | 5 (35.7) | 2 (14.3) | 14 (51.9) |